HK/China Healthcare Analyst (ex-Fosun Pharma)

Xinyao (Criss) Wang

Over 15 years' experience in both finance and healthcare, covering clinic operations, investment and equity research in both China and overseas.

Pre-IPO Amicro Technology (PHIP Updates) - Some Points Worth the Attention

Wuxi Biologics (2269 HK) Placement - Thought on Valuation and the Outlook

Pre-IPO Shenzhen Camsense Technologies (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Red Avenue New Materials Group (PHIP Updates) - Some Points Worth the Attention

Pre-IPO Beijing ESWIN Computing Technology (PHIP Updates) - The Strength and the Concerns

Equity Capital Markets

Shenzhen Transsion Holdings / Equity Capital Markets

<ul>
<li>Although Transsion holds an absolute leading position in African market, its fundamentals are in early stage of profit recovery, and it‘s facing dual uncertainties of patent litigation and intensified competition.</li>
<li>When competitors use mid-to-high-end models to encroach from above and use operator subsidies to pounce from below,Transsion lacks core product line with high profit margins to provide a profit buffer.</li>
<li>Transsion’s "multi-brand, full coverage" strategy is difficult to completely avoid the impact of the industry's downward cycle. Compared with peers, the A/H discount may fall within the range of 15%-25%.   </li>
</ul>


Although Transsion holds an absolute leading position in African market, its fundamentals are in early stage of profit recovery, and it‘s facing dual uncertainties of patent litigation and intensified competition.
When competitors use mid-to-high-end models to encroach from above and use operator subsidies to pounce from below,Transsion lacks core product line with high profit margins to provide a profit buffer.
Transsion’s "multi-brand, full coverage" strategy is difficult to completely avoid the impact of the industry's downward cycle. Compared with peers, the A/H discount may fall within the range of 15%-25%.   


Pre-IPO Shenzhen Transsion Holdings (PHIP Updates) - Some Points Worth the Attention